Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.500
-0.050 (-1.96%)
Apr 7, 2025, 3:37 PM EDT - Market open

Vivos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
152515952104
Upgrade
Market Cap Growth
69.64%69.64%61.00%-82.13%-50.41%-
Upgrade
Enterprise Value
102116525111
Upgrade
Last Close Price
2.554.2912.4410.0556.25147.75
Upgrade
PS Ratio
0.851.681.080.583.077.99
Upgrade
PB Ratio
1.893.1836.241.932.035.67
Upgrade
P/TBV Ratio
5.335.33-5.592.327.47
Upgrade
EV/Sales Ratio
0.681.371.160.341.458.51
Upgrade
Debt / Equity Ratio
0.190.194.850.500.050.07
Upgrade
Asset Turnover
1.161.161.130.680.570.80
Upgrade
Quick Ratio
1.341.340.250.583.433.10
Upgrade
Current Ratio
1.501.500.340.803.643.22
Upgrade
Return on Equity (ROE)
-266.25%-266.25%-521.22%-157.19%-92.31%-143.62%
Upgrade
Return on Assets (ROA)
-53.68%-53.68%-88.42%-66.00%-41.24%-33.11%
Upgrade
Return on Capital (ROIC)
-117.62%-117.62%-224.74%-91.98%-52.33%-49.96%
Upgrade
Earnings Yield
-74.15%-44.07%-91.20%-257.76%-39.18%-11.55%
Upgrade
FCF Yield
-88.29%-52.48%-85.93%-221.72%-35.02%-5.56%
Upgrade
Buyback Yield / Dilution
-311.68%-311.68%-32.46%-8.39%-65.00%-4.36%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q